Parian Global Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,600
Closed -$89K 30
2021
Q4
$89K Buy
+5,600
New +$112K 0.07% 33

Other funds holding RNLX

Parian Global Management's RNLX Position: Q3 2022 in Review

Parian Global Management reduced its Renalytix plc American Depositary Shares (RNLX) stake by 53% in Q3 2022, selling an estimated $460K and leaving 184,799 shares worth $237K. The position accounts for 0.77% of the portfolio, ranked #24.

Parian Global Management first reported a position in RNLX in Q3 2020 and has held it in 9 quarters since. The position peaked at $21.4M in Q1 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Parian Global Management held 184,799 shares of Renalytix plc American Depositary Shares worth $237K as of Q3 2022.
  • Parian Global Management sold 211,083 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $460K.
  • Renalytix plc American Depositary Shares made up 0.77% of Parian Global Management's portfolio in Q3 2022, its #24 holding.
  • Parian Global Management first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and has held it in 9 quarters since.
  • Parian Global Management's Renalytix plc American Depositary Shares position peaked at $21.4M in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.